tiprankstipranks
Eliem Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe FlyEliem Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
1y ago
Eliem :CEO Azelby, COO & CFO Lavelle, and Jim Bucher, general counsel, to depart
PremiumThe Fly
Eliem :CEO Azelby, COO & CFO Lavelle, and Jim Bucher, general counsel, to depart
1y ago
Eliem to re-prioritize pipeline, reduce workforce by 55% in 1H23
PremiumThe Fly
Eliem to re-prioritize pipeline, reduce workforce by 55% in 1H23
1y ago
Eliem Therapeutics to Participate at Two Upcoming Investor Conferences
PremiumPress ReleasesEliem Therapeutics to Participate at Two Upcoming Investor Conferences
1y ago
Eliem Therapeutics Provides Update on Pipeline Progress
PremiumPress Releases
Eliem Therapeutics Provides Update on Pipeline Progress
2y ago
Eliem Therapeutics Reports Second Quarter Financial and Business Highlights
PremiumPress Releases
Eliem Therapeutics Reports Second Quarter Financial and Business Highlights
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100